Postmenopausal hormone therapy and mortality.

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12

Psychosocial factors and public health: a suitable case for treatment? J Epidemiol Community Health (2003) 2.53

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut (2000) 1.81

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med (2006) 1.76

Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril (2011) 1.74

Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study. Menopause (2011) 1.67

Risk factors for mortality in the nurses' health study: a competing risks analysis. Am J Epidemiol (2010) 1.61

The privatization of risk. Am J Public Health (2001) 1.59

Synthesising licensing data to assess drug safety. BMJ (2004) 1.48

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47

Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause (2006) 1.46

[How dangerous is hormone replacement therapy (HRT) in menopause?]. Wien Klin Wochenschr (2004) 1.39

Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res (2000) 1.38

Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer (1999) 1.30

Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.25

Parenting and survival in anthropoid primates: caretakers live longer. Proc Natl Acad Sci U S A (1998) 1.24

Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens (2011) 1.24

Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer (2000) 1.15

Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors. J Am Soc Mass Spectrom (2005) 1.15

Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol (2009) 1.10

The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine (2005) 1.10

Hormone replacement therapy. BMJ (1998) 1.09

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Womens Health (2007) 1.07

Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens. Chem Res Toxicol (2010) 1.07

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02

Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus. J Biol Chem (2009) 0.99

Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy. Br J Pharmacol (2005) 0.97

Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study. Br J Cancer (2005) 0.95

Endothelial progenitor cells enter the aging arena. Front Physiol (2012) 0.94

Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer (1999) 0.93

Postmenopausal hormone-replacement therapy--time for a reappraisal? N Engl J Med (1997) 0.90

Translesion synthesis past equine estrogen-derived 2'-deoxyadenosine DNA adducts by human DNA polymerases eta and kappa. Biochemistry (2006) 0.90

Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction. Exp Physiol (2008) 0.90

Mechanism of translesion synthesis past an equine estrogen-DNA adduct by Y-family DNA polymerases. J Mol Biol (2007) 0.89

Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations. Am J Public Health (2000) 0.89

Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci (2002) 0.86

Debate: The potential role of estrogen in the prevention of heart disease in women after menopause. Curr Control Trials Cardiovasc Med (2000) 0.85

Low use of long-term hormone replacement therapy in Denmark. Br J Clin Pharmacol (1999) 0.85

Screening mammography intervals among postmenopausal hormone therapy users and nonusers. Cancer Causes Control (2009) 0.85

Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Ther (2009) 0.85

Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. Invest Ophthalmol Vis Sci (2009) 0.83

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83

Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study. BMC Cancer (2012) 0.81

Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies. J Zhejiang Univ Sci B (2014) 0.81

The dietary ingredient, genistein, stimulates cathelicidin antimicrobial peptide expression through a novel S1P-dependent mechanism. J Nutr Biochem (2014) 0.79

Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study. Br J Clin Pharmacol (2011) 0.79

Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals. BMJ (1998) 0.79

Autonomic Cardiovascular Damage during Post-menopause: the Role of Physical Training. Aging Dis (2013) 0.79

Quantitative detection of 4-hydroxyequilenin-DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody. Nucleic Acids Res (2010) 0.78

Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones. J Am Chem Soc (2009) 0.78

Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk. Ann Surg (1998) 0.78

Response of human mammary epithelial cells to DNA damage induced by 4-hydroxyequilenin: Lack of p53-mediated G1 arrest. Chem Biol Interact (2006) 0.78

Endothelial biology in the post-menopausal obese woman. Maturitas (2011) 0.78

Modulatory effects of alpha- and gamma-tocopherols on 4-hydroxyestradiol induced oxidative stresses in MCF-10A breast epithelial cells. Nutr Res Pract (2009) 0.77

Post-genomic update on a classical candidate gene for coronary artery disease: ESR1. Circ Cardiovasc Genet (2011) 0.77

Gender and communal trait differences in the relations among social behaviour, affect arousal, and cardiac autonomic control. J Behav Med (2005) 0.77

Reduction of post injury neointima formation due to 17beta-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro. BMC Cardiovasc Disord (2002) 0.77

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 0.76

Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group. Br J Cancer (1998) 0.76

Ways to make "usual" and "successful" aging synonymous. Preventive gerontology. West J Med (1997) 0.75

Pulse Wave Velocity in Postmenopausal Women. Pulse (Basel) (2013) 0.75

Recent advances. General medicine. BMJ (1998) 0.75

Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study. Am J Public Health (2016) 0.75

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 0.75

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 0.75

The Effect of Neurobehavioral Test Performance on the All-Cause Mortality among US Population. Biomed Res Int (2016) 0.75

Treatment of the menopause: the swinging pendulum. Facts Views Vis Obgyn (2010) 0.75

Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart (1998) 0.75

Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan. PLoS One (2015) 0.75

An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85

Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med (1995) 15.80

Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98

No hiding place: on the discomforts of researching the contemporary policy process. J Soc Policy (1990) 8.97

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43